[μ-(4S,5S,15S,16S)-10,21-Di-tert-butyl-4,5,15,16-tetra­phenyl-3,6,14,17-tetra­aza­tricyclo­[17.3.1.18,12]tetra­cosa-1(23),8,10,12(24),19,21-hexa­ene-23,24-diolato-κ8 N 3,N 6,O 23,O 24:N 14 N 17,O 23,O 24]bis­[(acetato-κO)zinc(II)] ethanol disolvate

@inproceedings{Fan20094S5S15S16S1021Ditertbutyl451516tetraph,
  title={[μ-(4S,5S,15S,16S)-10,21-Di-tert-butyl-4,5,15,16-tetra­phenyl-3,6,14,17-tetra­aza­tricyclo­[17.3.1.18,12]tetra­cosa-1(23),8,10,12(24),19,21-hexa­ene-23,24-diolato-κ8
               N
               3,N
               6,O
               23,O
               24:N
               14
               N
               17,O
               23,O
               24]bis­[(acetato-κO)zinc(II)] ethanol disolvate},
  author={Li-Jing Fan and Jian-Fang Ma and Jie Liu},
  booktitle={Acta crystallographica. Section E, Structure reports online},
  year={2009}
}
In the title compound, [Zn(2)(C(36)H(42)N(4)O(2))(CH(3)COO)(2)]·2CH(3)CH(2)OH, a centrosymmetric dinuclear zinc macrocyclic complex is accompanied by two half-occupied ethanol solvent molecues resulting in a 1:2 macrocycle-solvent composition. The Zn(II) atom has a square-pyramidal geometry arising from an N(2)O(3) donor set, being coordinated by two N atoms and two O atoms from the macrocyclic ligand in the equatorial sites and one O atom from an acetate anion in the apical site. The two Zn(II… CONTINUE READING